Literature DB >> 7636505

Mutations of some critical amino acid residues in the hepatitis B virus surface antigen.

S A Bruce1, K Murray.   

Abstract

Amino acid substitutions at several positions in the surface antigen (HBsAg) of hepatitis B virus (HBV) in natural isolates and the products of recombinant DNA molecules have identified important residues for cross-reaction with specific antibodies (anti-HBs) and the induction of antibodies with certain serological specificities. In a further group of mutants described here, cysteine residues in a region believed to be significant of the a epitope have been changed to serines. Of the three adjacent cysteine residues at positions 137, 138 and 139, mutation of either of the flanking residues reduced cross-reactivity with polyclonal anti-HBs, while alteration of the central residue was relatively well-tolerated. Mutation of cysteine 149 to serine or of glycine 145 to arginine (imitating naturally occurring mutants), lysine, or glutamatic acid all led to loss of cross-reactivity with polyclonal antisera.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636505     DOI: 10.1002/jmv.1890460214

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  The polymerase chain reaction--a time of transition from research to routine.

Authors:  T J Harrison
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 2.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

3.  Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen.

Authors:  P C Tai; D Banik; G I Lin; S Pai; K Pai; M H Lin; G Yuoh; S Che; S H Hsu; T C Chen; T T Kuo; C S Lee; C S Yang; C Shih
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.

Authors:  Hua-Biao Chen; De-Xing Fang; Fa-Qing Li; Hui-Ying Jing; Wei-Guo Tan; Su-Qin Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

5.  Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient.

Authors:  Alexandra Alexopoulou; Gerasimos Baltayiannis; Saffie Jammeh; Jenny Waters; Spyros P Dourakis; Peter Karayiannis
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.

Authors:  Se Ho Kim; Se Ho Kim; Han Kyu Oh; Chun Jeih Ryu; Song Yong Park; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

Review 7.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.